Trastuzumab Treatment in T1ab, Node-Negative, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Carcinomas-Reference-Cited by-同舟云学术

Trastuzumab Treatment in T1ab, Node-Negative, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Carcinomas

Published:2010-10-01 Issue:28 Volume:28 Page:e541-e542
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Rodrigues Manuel Jorge¹,Wassermann Johanna²,Albiges Laurence³,Brain Etienne²,Delaloge Suzette³,Stevens Denise²,Guinebretière Jean-Marc²,Mathieu Marie-Christine³,Kirova Youlia¹,Guillot Eugénie¹,Vincent-Salomon Anne¹,Cottu Paul H.¹

Affiliation:

1. Institut Curie, Paris, France

2. Centre René Huguenin, Saint Cloud, France

3. Institut Gustave Roussy, Villejuif, France

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.29.7952

Reference13 articles.

1. Medical audit after 26,711 breast imaging studies

2. High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller

3. Clinical Relevance of HER2 Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer

4. Refining Therapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: T Stands for Trastuzumab, Tumor Size, and Treatment Strategy

5. Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of 940 Chinese patients with triple-positive breast cancer by clinicopathological and treatment outcomes;2022-10-11

2. Factors Influencing Adjuvant Chemotherapy and Trastuzumab Choice in Older Human Epidermal Growth Factor Receptor 2-positive Breast Cancer Patients;Journal of Cancer;2020

3. Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer;South Asian Journal of Cancer;2018-04

4. A Value-Based Approach to Treatment of HER2-Positive Breast Cancer: Examining the Evidence;American Society of Clinical Oncology Educational Book;2016-05

5. Infracentimetric HER-2 positive breast tumours—review of the literature;ecancermedicalscience;2015-11-18